CEL-SCI CORPORATION Common Stock, Value, Issued
CEL-SCI CORPORATION (CVM) had Common Stock, Value, Issued of $173.08 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-14
- 2026-06-30: Common Stock, Value, Issued $173.08K.
- 2026-03-31: Common Stock, Value, Issued $82.12K.
- 2025-12-31: Common Stock, Value, Issued $80.55K.
- 2025-09-30: Common Stock, Value, Issued $80.16K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $173.08K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $82.12K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $80.55K 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $80.16K 10-Q · filed 2026-08-14 | |
| 2025-06-30 | $53.21K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $843.50K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $730.84K 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $21.27K 10-K · filed 2025-12-29 | $637.87K 10-K · filed 2025-01-13 |
| 2024-06-30 | $542.58K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $540.84K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $500.19K 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $474.22K 10-K · filed 2025-01-13 | |
| 2023-06-30 | $447.48K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $437.88K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $437.26K 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $434.48K 10-K · filed 2023-12-21 | |
| 2022-06-30 | $433.56K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $433.05K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $432.59K 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $432.07K 10-K · filed 2022-12-27 | |
| 2021-06-30 | $429.63K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $408.24K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $397.67K 10-Q · filed 2021-02-12 | |
| 2020-09-30 | $387.30K 10-K · filed 2021-12-21 | |
| 2020-06-30 | $385.22K 10-Q/A · filed 2020-12-31 | |
| 2020-03-31 | $373.37K 10-Q/A · filed 2020-12-30 | |
| 2019-12-31 | $359.95K 10-Q/A · filed 2020-12-30 | |
| 2019-09-30 | $352.32K 10-Q/A · filed 2020-12-31 | |
| 2019-06-30 | $340.67K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $299.52K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $278.44K 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $280.35K 10-K/A · filed 2019-12-23 | |
| 2018-06-30 | $195.71K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $166.25K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $132.58K 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $119.03K 10-K · filed 2018-12-19 | |
| 2017-06-30 | $92.19K 10-Q/A · filed 2017-12-11 | |
| 2017-03-31 | $86.56K 10-Q/A · filed 2017-12-11 | $2.16M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $76.34K 10-Q/A · filed 2017-12-11 | $1.91M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $62.48K 10-K · filed 2017-12-29 | $1.56M 10-K · filed 2016-12-15 |
| 2016-06-30 | $1.45M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.35M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $1.30M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $44.91K 10-K/A · filed 2017-12-11 | $1.12M 10-K · filed 2015-12-11 |
| 2015-06-30 | $1.12M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $915.49K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $914.83K 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $819.02K 10-K · filed 2015-12-11 | |
| 2014-06-30 | $660.42K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $582.77K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $558.53K 10-Q · filed 2014-02-10 | |
| 2013-09-30 | $310.25K 10-K · filed 2014-12-23 | |
| 2013-06-30 | $3.10M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $3.09M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $3.09M 10-Q · filed 2013-02-08 | |
| 2012-09-30 | $273.13K 10-K · filed 2013-12-27 | $2.73M 10-K · filed 2012-12-14 |
| 2012-06-30 | $2.73M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $2.57M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $2.30M 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $2.15M 10-K · filed 2012-12-14 | |
| 2011-06-30 | $2.11M 10-Q · filed 2011-08-09 | |
| 2010-09-30 | $2.05M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |